Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.48
+0.55 (7.93%)
Nov 21, 2024, 1:39 PM EST - Market open
Silence Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 61.95 | 54.03 | 54.82 | 73.54 | 27.45 | 13.52 | Upgrade
|
Short-Term Investments | 67.04 | - | 16.33 | - | 10 | 20 | Upgrade
|
Cash & Short-Term Investments | 128.99 | 54.03 | 71.14 | 73.54 | 37.45 | 33.52 | Upgrade
|
Cash Growth | 119.33% | -24.05% | -3.25% | 96.37% | 11.73% | 26.30% | Upgrade
|
Accounts Receivable | 0.29 | 0.23 | 0.92 | 0.33 | 29.31 | 0 | Upgrade
|
Other Receivables | 16.27 | 18.61 | 16.43 | 8.16 | 4.21 | 3.51 | Upgrade
|
Receivables | 16.56 | 18.83 | 17.34 | 8.49 | 33.52 | 3.52 | Upgrade
|
Prepaid Expenses | - | 8.16 | 8.2 | 4.31 | 3.94 | 0.43 | Upgrade
|
Other Current Assets | 11.96 | - | - | - | 1.49 | - | Upgrade
|
Total Current Assets | 157.51 | 81.02 | 96.69 | 86.33 | 76.4 | 37.47 | Upgrade
|
Property, Plant & Equipment | 1.65 | 1.81 | 2.2 | 1.94 | 1.13 | 0.61 | Upgrade
|
Long-Term Investments | 0.28 | 0.28 | 0.28 | 0.3 | 0.3 | 0.28 | Upgrade
|
Goodwill | 7.54 | 7.84 | 8.01 | 7.59 | 8.13 | 7.69 | Upgrade
|
Other Intangible Assets | 0.26 | 0.28 | 0.32 | 0.02 | 0.02 | 0.03 | Upgrade
|
Other Long-Term Assets | 2.14 | 2.58 | - | - | - | - | Upgrade
|
Total Assets | 169.38 | 93.82 | 107.5 | 96.19 | 85.97 | 46.08 | Upgrade
|
Accounts Payable | 14.27 | 2.63 | 3.19 | 4.07 | 2.29 | 1.79 | Upgrade
|
Accrued Expenses | - | 9.43 | 8.86 | 6.53 | 5.91 | 5.1 | Upgrade
|
Current Portion of Leases | 0.14 | 0.18 | 0.45 | 0.14 | 0.34 | 0.29 | Upgrade
|
Current Income Taxes Payable | - | 0.37 | 0.59 | 0.19 | - | - | Upgrade
|
Current Unearned Revenue | 2.5 | 5.16 | 8.86 | 4.25 | 17.04 | 2.48 | Upgrade
|
Total Current Liabilities | 16.91 | 17.77 | 21.94 | 15.17 | 25.58 | 9.65 | Upgrade
|
Long-Term Leases | - | 0.09 | - | - | - | - | Upgrade
|
Long-Term Unearned Revenue | 57.96 | 58.91 | 63.49 | 72.5 | 51.34 | 15.52 | Upgrade
|
Total Liabilities | 74.87 | 76.77 | 85.43 | 87.67 | 76.91 | 25.17 | Upgrade
|
Common Stock | 7.08 | 5.94 | 5.39 | 4.49 | 4.17 | 3.92 | Upgrade
|
Additional Paid-In Capital | - | 251.45 | 226.67 | 184.33 | 153.73 | 138.15 | Upgrade
|
Retained Earnings | -346.65 | -304.61 | -263.26 | -222.97 | -184.22 | -152 | Upgrade
|
Comprehensive Income & Other | 434.08 | 64.27 | 53.28 | 42.67 | 35.38 | 30.84 | Upgrade
|
Shareholders' Equity | 94.52 | 17.05 | 22.07 | 8.53 | 9.06 | 20.91 | Upgrade
|
Total Liabilities & Equity | 169.38 | 93.82 | 107.5 | 96.19 | 85.97 | 46.08 | Upgrade
|
Total Debt | 0.14 | 0.27 | 0.45 | 0.14 | 0.34 | 0.29 | Upgrade
|
Net Cash (Debt) | 128.85 | 53.76 | 70.7 | 73.4 | 37.11 | 33.23 | Upgrade
|
Net Cash Growth | 120.27% | -23.96% | -3.68% | 97.80% | 11.67% | 25.22% | Upgrade
|
Net Cash Per Share | 2.92 | 1.45 | 2.20 | 2.48 | 1.36 | 1.33 | Upgrade
|
Filing Date Shares Outstanding | 47.14 | 46.5 | 35.95 | 29.93 | 27.77 | 26.12 | Upgrade
|
Total Common Shares Outstanding | 47.14 | 39.62 | 35.94 | 29.93 | 27.77 | 26.12 | Upgrade
|
Working Capital | 140.6 | 63.25 | 74.74 | 71.17 | 50.82 | 27.81 | Upgrade
|
Book Value Per Share | 2.00 | 0.43 | 0.61 | 0.28 | 0.33 | 0.80 | Upgrade
|
Tangible Book Value | 86.72 | 8.93 | 13.74 | 0.91 | 0.92 | 13.18 | Upgrade
|
Tangible Book Value Per Share | 1.84 | 0.23 | 0.38 | 0.03 | 0.03 | 0.50 | Upgrade
|
Machinery | - | 5.06 | 4.99 | 5.11 | 4.07 | 3.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.